Shakil Aslam
Chief Medical OfficerDr. Shakil Aslam, M.D., was Chief Development Officer of Talphera, Inc. from May 20, 2024 until 2024 and serves as its Chief Medical Officer from October 01, 2024. Dr. Aslam joined the Talphera, Inc. on May 20, 2024. Dr. Aslam has clinical and research experience across a broad therapeutic range including renal and vascular disease and acute kidney injury. He served at BioCryst Pharmaceuticals where he was the Vice President, Clinical Development, Nephrology and Rare Diseases. Dr. Aslam previously held roles at Angion Biomedica, Fresenius Medical Care and Amgen and was an assistant professor at Georgetown University hospital for many years with a focus on acute and chronic kidney disease, hypertension, renal transplantation and other nephrological diseases.
Positions
- Company NameTalphera, Inc.Stock CodeTLPHPositionChief Medical Officer
